AQR Capital Management »

Inozyme Pharma shares owned by AQR Capital Management

Quarter-by-quarter ownership of Inozyme Pharma (INZY) shares owned by AQR Capital Management from 13F filings

Historical chart of AQR Capital Management investment in Inozyme Pharma

Tip: Access up to 7 years of quarterly data

All positions including Inozyme Pharma held by AQR Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Inozyme Pharma by AQR Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $196k 46k 4.26
2023-09-30 $83k 20k 4.20

More positions owned by AQR Capital Management

Apple (AAPL)
Microsoft Corporation (MSFT)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Taiwan Semiconductor Mfg Sponsored Ads (TSM)
Alphabet Cap Stk Cl A (GOOGL)
Meta Platforms Cl A (META)
Cisco Systems (CSCO)
Adobe Systems Incorporated (ADBE)
Broadcom (AVGO)
Alphabet Cap Stk Cl C (GOOG)
Pulte (PHM)
Cigna Corp (CI)
Humana (HUM)
CVS Caremark Corporation (CVS)

View all positions for AQR Capital Management

Top funds holding Inozyme Pharma

Samlyn Capital
Eventide Asset Management
NEA Management Company
Vanguard Group
Sphera Funds Management
Samsara BioCapital
Blue Owl Capital Holdings
Millennium Management
Laurion Capital Management
Octagon Capital Advisors
Goldman Sachs Group
Kennedy Capital Management
Overbrook Management Corp.
Citadel Advisors
GSA Capital Partners

View all funds holding Inozyme Pharma